Category Archives: Biotech

Biotech Spotlight

August 24, 2026 By in $SPSIBI, Biotech, Ed Dowd, Greg Hunter, LABD, LABD-26-10, SPBIO, Speck-Effect, Spring-to-Up-Thrust, The Speck, XBI, ZeroHedge Leave a comment

Potential Set-Up

Over the weekend, Greg Hunter released his latest interview with Ed Dowd, link here.

ZeroHedge subsequently picked up that feed, link here.

As is typical with ZeroHedge, the comments are a veritable gold-mine. In the like above, they don’t disappoint.

With XBI, we have our repeating pattern, link here.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … Downside Reversal?

August 16, 2026 By in Biotech, IBB, Wyckoff, The Speck, Speck-Effect, Up-Thrust, Karen Kingston, IBB-26-02 Leave a comment

Alignment of Forces

The last two updates, here and here, presented the case, forces are lining up; probability’s increasing for a downside reversal.

This update will complete the session (so far) on that potential.

Let’s not forget, behind-the-scenes (for years) stories like this and this continue to bubble to the surface.

Biotech IBB, Weekly

Last week’s trading range was significantly more narrow (with volume higher) than the week prior.

The chart shows IBB finished at or near the top of the wedge boundary and in Wyckoff ‘up-thrust’ position.

The ‘more’ promised at the end of yesterday’s update; Friday’s daily volume contracted on the test.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech ‘Dissected’

August 15, 2026 By in Biotech, IBB, IBB-26-02 1 Comment

Looking at The Inside

Yesterday’s update showed biotech sector IBB, in a bearish divergence.

The list of components can be found here.

For today, we’ll look at some of the technical characteristics pointing to potential for a downside reversal (not advice, not a recommendation).

Biotech IBB, Weekly

A wedge typically occurs at the end of a move, whether up or down (not advice, not a recommendation).

Price action has met the ‘measured move’ target and even gone slightly above.

The potential bearish MACD is shown.

If the coming week is flat or down, we’ll (likely) have a tick lower in MACD, completing the divergence signal.

Fo the next update, we’ll discuss a much larger ‘terminating’ wedge and more.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech’s Dual Divergence

August 14, 2026 By in Biotech, IBB, IBB-26-02, Spring-to-Up-Thrust 2 Comments

Daily & Weekly

The daily chart of IBB (left), and the weekly, are both posting bearish divergences.

Caveat: Strictly speaking, on the weekly chart, the MACD has yet to tick lower.

However, if next week’s action holds steady or posts lower, we’ll likely get that signal as well (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … Test & Reverse

May 1, 2026 By in $SPSIBI, Biotech, SPBIO, Spring-to-Up-Thrust, Up-Thrust, XBI, XBI-26-05

Pivot Lower

This week, biotech XBI, broke below support and then came back to test.

Today printed a new daily low (and closed lower), indicating the test may be complete.

Short trade: XBI-26-05, opened late in the session with a stop just above the day’s high (not advice not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Downside Breakaway … SOXX

March 21, 2026 By in $SPSIBI, Artificial Intelligence, Biotech, DIA, Dow 30, Nasdaq, NVDA, QQQ, SOXX, SPBIO, SPY, Wyckoff, XBI, XBI-26-04, YouTube Black Swan 2 Comments

Some Gaps, Never Filled

The day after the SOXX, topped on February 25th, was, this update.

In the case of Nvidia, it never printed or closed above the high reached on that day.

Well, the SOXX never made it back either.

Then, March 3rd, we have what looks like a ‘breakaway’ gap.

There’ve been at least two attempts to close that gap.

One of those attempts, a Wyckoff ‘spring’ set-up, which may have failed (not advice, not a recommendation).

Semiconductors SOXX, Daily

Other markets have rolled over as well; the Dow, S&P, the Qs, Biotech and so on (not advice, not a recommendation).

This just out, shows the typical response to an oil price shock, link here.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Confirms (so far)

March 19, 2026 By in $SPSIBI, Biotech, SPBIO, XBI, XBI-26-04

Downtrend Intact

Today’s action moved up, contacting the right side (supply side) trendline from yesterday’s update; then, pulled back.

For the short position, XBI-26-04. shown, the stop is just above today’s session high (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … Downside Ready

March 18, 2026 By in $SPSIBI, Biotech, Federal Reserve, SPBIO, XBI 3 Comments

Trading Channel

Biotech is one of those sectors that’s been elusive, hard to pin down.

The last update was in January, link here.

Note: that update identified the exact high (so far), for the sector; shown as ‘Day 1’, in the chart below.

Since then, it’s been what looks like mindless, sideways congestion; until yesterday, and today.

Before getting to the chart, recall there’s a Fed announcement coming up.

That may bring volatility, or it could be much ado about nothing.

Biotech XBI, Daily

There have been two contact points on the right side (supply side) of the channel; the most recent, during yesterday’s session.

As of this post, there are no short positions (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech (momentum) Bleeds-Off

January 24, 2026 By in $SPSIBI, Biotech, SPBIO, XBI, XBI-26-01

Lower, Monday?

Weeks of declining momentum for biotech XBI, may have culminated in an up thrust last Thursday

That push higher, led to Friday’s decline and new daily low (not advice, not a recommendation).

Recall, last time the ‘fundamentals’ were reviewed, seven of the of the top ten in market cap, had no P/E at all.

Biotech XBI, Weekly

Entire series: All-time highs-to-present.

Declining momentum, terminating wedge, ‘throw-over’.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Uber … in the Channel

January 5, 2026 By in $SPSIBI, Biotech, SPBIO, UBER, UBER-26-01, XBI 2 Comments

False Breakout?

The chart of Uber is similar to biotech XBI, from last year, link here.

Back then, it looked like there was a breakout from a trading channel.

That update said:

“If the trendline is in-effect, meaning the market’s hanging in mid-air in a false breakout, getting back into that trend may result in some dramatic downside action.”

That’s what happened. Biotech collapsed in to the ‘Tariff’ meltdown.

Is that where we are now, with UBER? (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279